HUTCHMED to divest 45% equity interest in SHPL for $608m
The move is part of HUTCHMED’s strategy to concentrate on its core business of developing new therapies for immunological diseases and cancers. Credit: THICHA SATAPITANON/Shutterstock.
The move is part of HUTCHMED’s strategy to concentrate on its core business of developing new therapies for immunological diseases and cancers. Credit: THICHA SATAPITANON/Shutterstock.
Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients
The U.S. Food and Drug Agency is not really a singular agency. In practice, it operates more like five or more “FDAs” — each covering drugs, devices,
The new year ushered in a final slate of updates to the federal rules for how hospitals have to disclose their prices, and experts are
The partnership involves the development of an ADC for the treatment of individuals with advanced small cell lung cancer. Credit: Jo Panuwat D/Shutterstock. Innovent Biologics
Researchers have come up with a new way to identify more infectious variants of viruses or bacteria that start spreading in humans – including those
A recent study published in Health Data Science led by Zhilong Zhang from the Institute of Medical Technology at Peking University Health Science Center and
Ebola is a deadly hemorrhagic disease caused by a virus that is endemic in parts of East-Central and West Africa. Most people are aware that
Based on new brain mapping research funded by the National Institutes of Health (NIH), scientists have discovered that not all cell types in the brain
Cornell University researchers have found the pupil is key to understanding how, and when, the brain forms strong, long-lasting memories.